I’m still confused. Which party initiated the action in Victoria? Surely 4Dmedical?
Either way this is more expense! Unless it’s ’no win no fee’?
The R&D tax credit is an offset against expenditure. Grant funding is to varying degrees (depending upon the milestones) a payment against expenditure paid in arrears. Reconciling government grant announcements with the annual reports it appears the company may have failed to achieve milestones in the past with payments not being brought to book.
My fear is that the ratio of expenditure:revenue is about to grow even larger.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $135.0M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.0¢ | 27.5¢ | $309.2K | 1.097M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1754 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 5595 | 2 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| 4DX (ASX) Chart |